Influence of delays in diagnosis and treatment on survival in small cell lung cancer patients

Advances in Experimental Medicine and Biology

Volumn 788, Issue , 2013, Pages 355-362

  Radzikowska, E ^a   Roszkowski Sliz, K ^a   Chabowski, M ^a   Glaz, P ^a  

^a NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

Author keywords

Diagnosis delay; Hazard ratio; Performance status; Prognosis; Small cell lung cancer; Survival; Therapy

Indexed keywords

ADULT; ARTICLE; BRONCHOSCOPY; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; DELAYED DIAGNOSIS; EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS; FEMALE; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OVERALL SURVIVAL; PATIENT REFERRAL; POLAND; PREDICTIVE VALUE; PRIORITY JOURNAL; SEX DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME; THERAPY DELAY; TIME TO TREATMENT; TREATMENT REFUSAL;

EID: 84881073525     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-007-6627-3_48     Document Type: Article

References (25)

1. Albain, K. S., Crowley, J. J., LeBlanc, M., & Livingston, R. B. (1990). Determinants of improved outcome in small cell lung cancer: An analysis of the 2580-patients. Southwest oncology group data base. Journal of Clinical Oncology, 8, 1563-1574. (Pubitemid 20301188)
2. Bilimora, K. Y., Ko, C. Y., Tomlinson, J. S., Stewart, A. K., Talamonti, M. S., Hynes, D. L., Winchester, D. P., & Bentrem, D. J. (2011). Wait times for cancer surgery in the United States: Trends and predictors of delays. Annals of Surgery, 253, 779-785.
3. Buccheri, G., & Ferrigno, D. (2004). Lung cancer: Clinical presentation and specialist referral time. The European Respiratory Journal, 24, 898-904. (Pubitemid 39642276)
4. Chen, J., Jiang, R., Graces, Y. I., Jatoi, A., Stoddard, S.M., Sun, Z., Marks, R. S., Liu, Y., & Young, P. (2010). Prognostic factors for limited-stage small cell lung cancer: A study of 284 patients. Lung Cancer, 67, 221-226.
5. Gonzalez-Barcala, F. J., Garcia-Prim, J. M., Alvarez-Dobano, J. M., Alvarez-Dobaño, J. M., Moldes-Rodŕguez, M., Garća-Sanz, M. T., Pose-Reino, A., & Valdés-Cuadrado, L. (2010). Effects of delays on survival in patients with lung cancer. Clinical & Translational Oncology, 12, 836-842.
6. International Union against Cancer. (1997). TNM classification of malignant tumors (5th ed., pp. 93-97). New York: Wiley-Liss.
7. Laskin, J. J., Erridge, S. C.,Coldman,A. J., D'yachkova,Y., Speers, C., Westeel, V., Hislop, T. G., Olivotto, I. A., & Murray, N. (2004). Population-based outcomes for small cell lung cancer: Impact of standard management policies in British Columbia. Lung Cancer, 43, 7-16. (Pubitemid 38096287)
8. Lassen, U., Osterlind, K., Hansen, M., Dombernowsky, P., Bergman, B., & Hansen, H. H. (1995). Long-term survival in small-cell lung cancer: Posttreatment characteristics in patients surviving 5 to 18+ years-an analysis of 1,714 consecutive patients. Journal of Clinical Oncology, 13, 1215-1220.
9. NLST updates. (2010). http://www.cancer.gov/newscenter/pressreleases/ 2010/NLSTresultsRelease. Accessed 8 Oct 2012.
10. Oken, M. M., Creech, R. H., Tormey, D. C., Horton, J., Davis, T. E., McFadden, E. T., & Carbone, P. P. (1982). Toxicity and response criteria of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology, 5, 649-655. (Pubitemid 13149996)
11. Olsson, J. K., Schultz, E. M., & Gould, M. K. (2009). Timeless of care in patients with lung cancer: Systematic review. Thorax, 64, 749-756.
12. Radzikowska, E., Glaz, P., & Roszkowski, K. (2001). Lung cancer-diagnosis and therapy delay. Pneumonologia i Alergologia Polska, 69, 600-610.
13. Radzikowska, E., Glaz, P., & Roszkowski, K. (2002). Lung cancer in women: Age, smoking, histology, PS, stage, initial treatment and survival. Population based study of 20561 cases. Annals of Oncology, 13, 1087-1093.
14. Rahman, S. M., Gonzalez, A. L., Li, M., Seeley, E. H., Zimmerman, L. J., Zhang, X. J., Manier, M. L., Olson, S. J., Shah, R. N., Miller, A. N., Putnam, J. B., Miller, Y. E., Franklin, W. A., Blot, W. J., Carbone, D. P., Shyr, Y., Caprioli, R. M., & Massion, P. P. (2011). Lung cancer diagnosis from proteomic analysis of preinvasive lesions. Cancer Research, 71, 3009-3017.
15. Senkus, E., Jassem, J., Karnicka-Mlodkowska, H., Welnicka-Jaskiewicz, M., Radzikowska, E., Broniek, A., Krawczyk, K., Malak, K., Kowal, E., & Mos-Antkowiak, R. (1994). Analysis of prognostic factors in long small cell lung cancer survivors. Pneumonologia i Alergologia Polska, 62, 233-238.
16. Shepherd, F. A., Crowley, J. J., Van Houtte, P., Postmus, P. E., Carney, D., Chansky, K., Shaikh, Z., & Goldstraw, P. (2007). The IASLC Lung Cancer Staging Project; proposal regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. Journal of Thoracic Oncology, 2, 1067-1077. (Pubitemid 350307898)
17. Siegel, R., Naishadhan, D., & Jemal, A. (2012). Cancer statistics, 2012. CA: A Cancer Journal for Clinicians, 62, 10-29.
18. Skaugh, K., Eide, G. E., & Gulsvik, A. (2011). Predictors of long-term survival of lung cancer patients in Norwegian community. The Clinical Respiratory Journal, 5, 50-58.
19. Spiro, S. G., Gould, M. K., & Colice, G. L. (2007). Initial evaluation of the patients with lung cancer; symptoms, signs, laboratory tests, and paraneoplastic syndromes. ACCP evidenced-based clinical practice guidelines. 2nd edition. Chest, 132, 149s-160s. (Pubitemid 47502805)
20. Tamura, M., Ueoka, H., Kiura, K. K., Tabata, M., Shibayama, T., Miyatake, K., Gemba, K., Hiraki, S., & Harada, M. (1998). Prognostic factors of small cell lung cancer in Okayama Lung Cancer Study Group trial. Acta Medica Okyayama, 52, 105-111. (Pubitemid 128456895)
21. The Lung Cancer Working Party of British Thoracic Society Standards of Care Committee. (1998). BTS-British Thoracic Society recommendations to respiratory physicians for organising the care of patients with lung cancer. Thorax, 53(Suppl 1), S1-S8.
22. The National Lung Cancer Screening Research Teem. (2011). Reduced lung cancer mortality with low-dose computed tomography screening. New England Journal of Medicine, 365, 395-409.
23. Turkington, P. M., Kennan, N., & Greenston, M. A. (2002). Misinterpretation of the chest X-ray as a factor in the delayed diagnosis of lung cancer. Postgraduate Medical Journal, 78, 158-160. (Pubitemid 34229623)
24. Tyczynski, J. E., Bray, F., Aareleid, T., Dalmas, M., Kurtinaitis, J., Plesko, I., Pompe-Kirn, V., Stengrevics, A., & Parkin, D. M. (2004). Lung cancer mortality patterns in selected central, Eastern and Southern European countries. International Journal of Cancer, 109, 598-610. (Pubitemid 38339652)
25. World Health Organization. (1981). Histological typing of lung cancer tumours. In International classification of tumors (2nd ed., Vol. 1). Geneva: World Health Organization.